Filed: 11/14/2022ACC: 0001567619-22-020103
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $432.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$432.2K
Total AUM (reported)
25.22M
Total Shares
Allocation by class
COM$432.2K100.0%
Portfolio Concentration
Top 3$328.9K76.1%
4–10$103.3K23.9%
Top 3 weight
76.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 25.22M
Sole
Full voting authority
25.22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
VENTYX BIOSCIENCES INC
SOLEShares5.01M
TypeSH
Market value$175.0K
40.48%
Sole
5.01M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$92.8K
21.48%
Sole
9.70M
Shared
0.00
None
0.00
CINCOR PHARMA INC
SOLEShares1.86M
TypeSH
Market value$61.1K
14.14%
Sole
1.86M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.13M
TypeSH
Market value$49.9K
11.53%
Sole
1.13M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares596.48K
TypeSH
Market value$20.3K
4.70%
Sole
596.48K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares2.30M
TypeSH
Market value$17.6K
4.08%
Sole
2.30M
Shared
0.00
None
0.00
IMPEL PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$13.4K
3.11%
Sole
2.76M
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares1.87M
TypeSH
Market value$2.1K
0.49%
Sole
1.87M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VENTYX BIOSCIENCES INCSOLE | COM | 5.01M | SH | $175.0K 40.48% | 5.01M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $92.8K 21.48% | 9.70M | 0.00 | 0.00 |
CINCOR PHARMA INCSOLE | COM | 1.86M | SH | $61.1K 14.14% | 1.86M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.13M | SH | $49.9K 11.53% | 1.13M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 596.48K | SH | $20.3K 4.70% | 596.48K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 2.30M | SH | $17.6K 4.08% | 2.30M | 0.00 | 0.00 |
IMPEL PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $13.4K 3.11% | 2.76M | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 1.87M | SH | $2.1K 0.49% | 1.87M | 0.00 | 0.00 |